MugiPocketOpen in App
Hibari EB03-008
Character · Cost 3 · 5,000 Power · Red · Rare
Market price · ungraded
$1.59
Updated 20 September 2026 · updated daily from tracked sales
As of 20 September 2026, Hibari EB03-008 (One Piece Heroines Edition) sells for about $1.59 ungraded. Updated: 20 September 2026.
Price history · last 90 days
Graded values · PSA population
$23.69PSA 10 · pop 764
$10.22PSA 9 · pop 117
$5.81PSA 8 · pop 39
$31.98BGS 10 Black Label
PSA 8 to 10 values and population
Open in AppCard effect
On Play/When Attacking Up to 1 of your {SWORD} type Leader or Character cards can also attack active Characters during this turn.
Activate: Main Once Per Turn Give up to 1 of your opponent's Characters −1000 power during this turn.
Activate: Main Once Per Turn Give up to 1 of your opponent's Characters −1000 power during this turn.
Card details
TypeCharacter
ColorRed
Cost3
Power5,000
RarityRare
AttributeRanged
TraitsNavy / SWORD
SetOne Piece Heroines Edition (EB03)
All printings of Hibari EB03-008
| Printing | Market | PSA 10 | Sales / yr |
|---|---|---|---|
| Base | $1.59 | ||
| Alternate Art | |||
| Alternate Art (JP) |
Price Intelligence
$1.75Fair value
+10%Upside to fair
0.92Liquidity score
Signal: Accumulate. Raw trades under fair value; population growth slowing.
$1.8690 day target
$1.39Support
15 / moPSA 10 new pop
Fair value, signal and grading edge live in the app
Free to open. Price Intelligence is a Pro feature with a 7 day trial.
Open in AppAbout this card
How much is Hibari EB03-008 worth? As of 20 September 2026, Hibari EB03-008 sells for about $1.59 ungraded, based on tracked market sales updated daily. Graded values, PSA population and the other printings are in the MugiPocket app.
Is the price of Hibari EB03-008 going up or down? The price of Hibari EB03-008 is -18% over the last 30 days, at $1.59 as of 20 September 2026.
Is Hibari EB03-008 worth grading? It depends on the raw to PSA 10 spread against the gem rate of this print. MugiPocket calculates the grading edge for every card from tracked sales and PSA population.